Investing Profile
Carlos Solórzano
Your Intro Paths to Carlos Solórzano
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Carlos is a member of
Deutsche Bank Network
51 CONNECTIONS
Find Carlos Solórzano on
cbCurrent Investing Position
Section 32 Principal
Previous Investment Position
Pivotal bioVenture Partners Sr. Associate
Investment Range
$10K - $50K
Sweet Spot
$25K
Current Fund Size
$740M
Carlos Solórzano is on these Sector & Stage Rankings
Therapeutics (Series B)Therapeutics (Series A)Therapeutics (Seed)Therapeutics (Series B)Therapeutics (Series A)Therapeutics (Seed)Digital Health (Series B)BioTech (Series B)Health IT (Series B)Health & Hospital Services (Series B)BioTech (Series A)Health & Hospital Services (Series A)Health & Hospital Services (Seed)Digital Health (Seed)Digital Health (Series A)Digital Health (Series B)BioTech (Seed)Health IT (Seed)Health IT (Series A)Health IT (Series B)BioTech (Series B)Digital Health (Series A)Health & Hospital Services (Series B)San Francisco Bay AreaBioTech (Series A)Digital Health (Seed)BioTech (Seed)Health & Hospital Services (Seed)Health & Hospital Services (Series A)Health IT (Series A)Health IT (Seed)
Carlos Solórzano's Experience
Sr. Principal Section 322022 - Present
Sr. Associate Pivotal Life Sciences2019 - 2022
Sr. Associate Pivotal bioVenture Partners2019 - 2022
Assoc Director, Corporate Strategy Ultragenyx Pharmaceutical Inc.2018 - 2019
Equity Research Associate - Biotechnology Deutsche Bank2016 - 2018
Equity Research Associate - Biotechnology Oppenheimer & Co. Inc.2015 - 2016
NIH Postdoctoral Fellow University of California, San Francisco2010 - 2015
President - Bay Area Chapter Oxbridge Biotech Roundtable2014 - 2014
Carlos Solórzano's Education
Keck Graduate Institute Intensive Summer Business Course
University of California, Irvine Ph.D. Pharmacology and Toxicology
California State Polytechnic University-Pomona B.Sc. Chemical Engineering
Investors who invest with Carlos Solórzano